Côd QR

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program

Background: Medications such as buprenorphine are considered the gold standard for the treatment of opioid use disorders. This study aimed to determine whether less restrictive buprenorphine prescribing practices during the COVID-19 pandemic impacted retention in and adherence to buprenorphine among...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Kathleen M. Ward, Ayden Scheim, Jonathan Wang, Benjamin Cocchiaro, Katie Singley, Alexis M. Roth
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2022-06-01
Cyfres:Drug and Alcohol Dependence Reports
Pynciau:
Opioid use disorder
Retention
Adherence
People who use drugs
Buprenorphine
COVID-19
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2772724622000336
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg